StockData
Fulgent Genetics, Inc. logo

Fulgent Genetics, Inc. (FLGT) stock

FLGTNasdaqServices-Medical LaboratoriesFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 7/3047% below fair value
$24.21+0.14 (+0.56%)

Close on Nov 17, 2026Market cap $666.15MP/E –Yield –

Fulgent Genetics r&d expenses

Research and development expenses are spending on new products and technology.

Fulgent Genetics's R&D Expenses for the twelve months ending Jun 30, 2026 was $56.76M, up 14.0% year over year. For fiscal 2025 it was $53.91M, up 10.4% from the year before. Over ten years it grew 28.4% a year on average. The highest annual figure on record is $53.91M in fiscal 2025.

Annual r&d expenses

PeriodPeriod endValueChange
FY2025Dec 31, 2025$53.91M+10.4%
FY2024Dec 31, 2024$48.82M+17.8%
FY2023Dec 31, 2023$41.44M+43.3%
FY2022Dec 31, 2022$28.91M+19.4%
FY2021Dec 31, 2021$24.22M+109.1%
FY2020Dec 31, 2020$11.58M+77.1%
FY2019Dec 31, 2019$6.54M+18.1%
FY2018Dec 31, 2018$5.53M+31.0%
FY2017Dec 31, 2017$4.22M+18.7%
FY2016Dec 31, 2016$3.56M-19.7%
FY2015Dec 31, 2015$4.43M+750.5%
FY2014Dec 31, 2014$521.00K–

Quarterly r&d expenses

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026$14.55M+8.0%
Q1 FY2026Mar 31, 2026$14.18M+14.4%
Q4 FY2025Dec 31, 2025$14.17M+17.0%
Q3 FY2025Sep 30, 2025$13.86M+17.6%
Q2 FY2025Jun 30, 2025$13.48M-0.0%
Q1 FY2025Mar 31, 2025$12.40M+8.4%
Q4 FY2024Dec 31, 2024$12.11M+1.3%
Q3 FY2024Sep 30, 2024$11.78M+17.7%
Q2 FY2024Jun 30, 2024$13.49M+39.1%
Q1 FY2024Mar 31, 2024$11.43M+16.9%
Q4 FY2023Dec 31, 2023$11.95M+40.5%
Q3 FY2023Sep 30, 2023$10.01M+33.4%
Q2 FY2023Jun 30, 2023$9.69M+40.4%
Q1 FY2023Mar 31, 2023$9.78M+63.3%
Q4 FY2022Dec 31, 2022$8.51M+14.0%
Q3 FY2022Sep 30, 2022$7.51M+24.7%
Q2 FY2022Jun 30, 2022$6.91M+30.0%
Q1 FY2022Mar 31, 2022$5.99M+10.5%
Q4 FY2021Dec 31, 2021$7.46M+63.1%
Q3 FY2021Sep 30, 2021$6.02M+89.5%
Q2 FY2021Jun 30, 2021$5.31M+187.3%
Q1 FY2021Mar 31, 2021$5.42M+174.1%
Q4 FY2020Dec 31, 2020$4.58M+154.9%
Q3 FY2020Sep 30, 2020$3.18M+82.2%
Q2 FY2020Jun 30, 2020$1.85M+17.5%
Q1 FY2020Mar 31, 2020$1.98M+38.9%
Q4 FY2019Dec 31, 2019$1.80M+25.9%
Q3 FY2019Sep 30, 2019$1.74M+21.3%
Q2 FY2019Jun 30, 2019$1.57M+29.9%
Q1 FY2019Mar 31, 2019$1.42M-2.3%
Q4 FY2018Dec 31, 2018$1.43M+7.7%
Q3 FY2018Sep 30, 2018$1.44M+27.5%
Q2 FY2018Jun 30, 2018$1.21M+31.7%
Q1 FY2018Mar 31, 2018$1.46M+71.3%
Q4 FY2017Dec 31, 2017$1.32M+61.9%
Q3 FY2017Sep 30, 2017$1.13M-25.9%
Q2 FY2017Jun 30, 2017$920.00K–
Q1 FY2017Mar 31, 2017$851.00K–
Q4 FY2016Dec 31, 2016$818.00K–
Q3 FY2016Sep 30, 2016$1.52M–

More Fulgent Genetics figures

See a number that looks wrong?